The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Looking for ways to earn money without spending? Discover effective strategies to boost your income without any upfront costs.
23,145 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
When insider moves hit the headlines, investors seek clarity. This piece breaks down what it means when the holdings ...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
SpaceX IPO excitement can tempt any investor, but the space sector is risky and competitive. This guide compares Spac...
Dream Finders Homes drives a hostile bid for Beazer as Sumitomo Forestry closes a $4.5 billion cash deal for Tri Poin...
Independent single-family rental owners are largely insulated from institutional competition, according to TurboTenan...
Natural gas equities are delivering higher yields than broad dividend ETFs as of 2026, driven by midstream cash flows...
CertifID debuts a mobile-first closing platform that centralizes identity verification, document signing, and payment...
A high-stakes order from China could reshape Boeing’s revenue trajectory. Here’s how to think about the stock in 2026...
A quiet quantum player is showing real-world traction while the hype focuses on the big names. This analysis reveals ...
When a CEO sells a large block of stock, investors take notice. This article breaks down what nLIGHT's sold nearly 25...
Public space stocks are quietly expanding the orbital economy ahead of SpaceX's IPO. This report surveys Rocket Lab, ...